FDA Inspection
UAB Teva BalticsUAB Teva Baltics – FDA Inspection, May 11, 2018
Record Details
This FDA Inspection record concerns UAB Teva Baltics, with an inspection on May 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 177a66f6-fbfe-47b7-bb59-a885ff9dc2c2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1057580
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of UAB Teva Baltics
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UAB Teva Baltics
- FDA Inspection 1270427 - 2024-05-09
- FDA Inspection 1124668 - 2019-05-23
- FDA Inspection 933280 - 2015-07-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.